Vaxcell-Bio Therapeutics Co., Ltd. (KOSDAQ: 323990)
13,940
-140 (-0.99%)
Sep 10, 2024, 9:00 AM KST
Vaxcell-Bio Therapeutics Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
Cash & Equivalents | 4,604 | 9,046 | 389.66 | 2,309 | 9,903 | 4,074 | Upgrade
|
Short-Term Investments | 45,000 | 41,000 | 20,002 | 25,000 | 9,000 | 4,000 | Upgrade
|
Cash & Short-Term Investments | 49,604 | 50,046 | 20,392 | 27,309 | 18,903 | 8,074 | Upgrade
|
Cash Growth | 214.08% | 145.42% | -25.33% | 44.47% | 134.10% | -29.46% | Upgrade
|
Accounts Receivable | 2.67 | 0.08 | - | - | - | - | Upgrade
|
Other Receivables | 1,853 | 581.97 | 210.31 | 353.21 | 96.63 | 96.31 | Upgrade
|
Receivables | 1,855 | 582.05 | 210.31 | 353.21 | 96.63 | 96.31 | Upgrade
|
Inventory | 158.09 | 96.74 | - | - | - | - | Upgrade
|
Prepaid Expenses | 118.04 | 185.45 | 190.31 | 504.84 | 70.66 | 90.75 | Upgrade
|
Other Current Assets | 332.03 | 316.92 | 105.7 | 30.62 | 116.37 | 55.81 | Upgrade
|
Total Current Assets | 52,067 | 51,227 | 20,898 | 28,197 | 19,186 | 8,317 | Upgrade
|
Property, Plant & Equipment | 6,571 | 2,674 | 2,541 | 2,804 | 1,142 | 1,557 | Upgrade
|
Long-Term Investments | 21,922 | 29,873 | -0 | -0 | 15,000 | -0 | Upgrade
|
Other Intangible Assets | 1,230 | 206.65 | 229.46 | 147.62 | 68.82 | 77.48 | Upgrade
|
Other Long-Term Assets | 1,353 | 999.18 | 494.03 | 126.87 | 100.88 | 83.47 | Upgrade
|
Total Assets | 83,143 | 84,980 | 24,163 | 31,276 | 35,498 | 10,036 | Upgrade
|
Accrued Expenses | 154.79 | 117.87 | 118.23 | 129.42 | 188.94 | 221.77 | Upgrade
|
Current Portion of Leases | 973.74 | 216.89 | 46.51 | 183.05 | 186.36 | 162.99 | Upgrade
|
Other Current Liabilities | 1,193 | 589.38 | 142.3 | 79.84 | 218.89 | 40.96 | Upgrade
|
Total Current Liabilities | 2,322 | 924.14 | 307.04 | 392.3 | 594.19 | 425.73 | Upgrade
|
Long-Term Leases | 1,784 | 144.34 | 58.72 | 37.39 | 152.75 | 300.63 | Upgrade
|
Other Long-Term Liabilities | 430.62 | 269.63 | 219.11 | 112.64 | 20.84 | - | Upgrade
|
Total Liabilities | 4,868 | 1,487 | 835.78 | 1,196 | 830.1 | 964.46 | Upgrade
|
Common Stock | 11,497 | 11,497 | 7,612 | 7,612 | 3,762 | 3,254 | Upgrade
|
Additional Paid-In Capital | 115,619 | 115,619 | 48,888 | 48,888 | 51,913 | 23,054 | Upgrade
|
Retained Earnings | -48,908 | -43,537 | -33,383 | -26,505 | -21,288 | -17,359 | Upgrade
|
Treasury Stock | -532.7 | -532.7 | - | - | - | - | Upgrade
|
Comprensive Income & Other | 599.8 | 447.51 | 210.35 | 85.39 | 280.14 | 121.16 | Upgrade
|
Total Common Equity | 78,275 | 83,493 | 23,327 | 30,080 | 34,667 | 9,071 | Upgrade
|
Shareholders' Equity | 78,275 | 83,493 | 23,327 | 30,080 | 34,667 | 9,071 | Upgrade
|
Total Liabilities & Equity | 83,143 | 84,980 | 24,163 | 31,276 | 35,498 | 10,036 | Upgrade
|
Total Debt | 2,757 | 361.23 | 105.24 | 220.44 | 339.11 | 463.62 | Upgrade
|
Net Cash (Debt) | 46,846 | 49,685 | 20,287 | 27,088 | 18,563 | 7,611 | Upgrade
|
Net Cash Growth | 203.07% | 144.91% | -25.11% | 45.92% | 143.91% | 199.50% | Upgrade
|
Net Cash Per Share | 1994.20 | 2532.94 | 1064.12 | 1791.57 | 2725.80 | 1736.13 | Upgrade
|
Filing Date Shares Outstanding | 23.07 | 22.96 | 18.27 | 18.27 | 9.03 | 4.38 | Upgrade
|
Total Common Shares Outstanding | 23.07 | 22.96 | 18.27 | 18.27 | 9.03 | 4.38 | Upgrade
|
Working Capital | 49,745 | 50,303 | 20,591 | 27,805 | 18,592 | 7,892 | Upgrade
|
Book Value Per Share | 3393.47 | 3635.75 | 1276.97 | 1646.65 | 3840.16 | 2069.29 | Upgrade
|
Tangible Book Value | 77,045 | 83,287 | 23,098 | 29,933 | 34,599 | 8,994 | Upgrade
|
Tangible Book Value Per Share | 3340.16 | 3626.75 | 1264.41 | 1638.57 | 3832.54 | 2051.61 | Upgrade
|
Land | 1,602 | 1,602 | 1,602 | 1,602 | - | - | Upgrade
|
Machinery | 3,986 | 2,489 | 2,346 | 2,213 | 1,717 | 1,689 | Upgrade
|
Construction In Progress | - | 22.51 | - | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.